Table 1.
Demographic characteristics
| Variable (Number of patients) |
AION (n=191) |
Amaurosis Fugax (n=44) |
BRAO (n=119) |
CRAO (n=196) |
Ocular ischemic syndrome (n=64) |
|---|---|---|---|---|---|
| Sex (male) | 112 (59%) | 26 (59%) | 80 (67%) | 110 (56%) | 43 (67%) |
|
Age (at onset or visit1) |
|||||
| Mean (SD) | 60.8 (12.5) | 65.9 (10.0) | 62.9 (12.8) | 67.1 (13.3) | 69.5 (8.3) |
| Range | 26–91 | 46–87 | 22–86 | 16–90 | 49–85 |
| Involved side | |||||
| Right eye | 63 (33%) | 17 (39%) | 52 (44%) | 95 (48%) | 23 (36%) |
| Left eye | 53 (28%) | 19 (43%) | 60 (50%) | 94 (48%) | 25 (39%) |
| Both eyes | 75 (39%) | 8 (18%) | 7 (6%) | 7 (4%) | 16 (25%) |
|
Onset to first visit (wks) |
(n=189) | (n=42) | (n=115) | (n=195) | (n=49) |
| Median [IQR] | 2.4 [1.0–5.3] | 8.0 [2,1–36.3] | 1.1 [0.3–7.4] | 1.0 [0.1–4.1] | 9.7 [2.0–28.4] |
| Range | 0–218 | 0–271 | 0–240 | 0–162 | 0–428 |
| Follow-up (yrs) | |||||
| Median [IQR] | 3.3 [1.2–8.2] | 1.4 [0.2–3.4] | 1.8 [0.2–4.7] | 0.7 [0.2–3.4] | 0.9 [0.1–3.8] |
| Range | 0–20.7 | 0–21.8 | 0–24.1 | 0–20.4 | 0–17.4 |
| <3 months | 19 (10%) | 11 (25%) | 30 (25%) | 66 (34%) | 19 (30%) |